Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "8"

News & Events

Every Friday: Child Health Research Seminars 2014

Associate Professor Roz Walker has been involved in research, evaluation and education with Aboriginal communities building local capacity for 30 years.

News & Events

Trans Tasman action to fast track rheumatic fever vaccine

Prime Ministers of Australia and New Zealand have agreed to provide $3M to help fast-track the development of a vaccine against rheumatic fever.

News & Events

Investigational vaccine for WA's meningococcal threat

Perth researchers have begun a clinical trial of an investigational Meningococcal B vaccine against the most common form of meningococcal disease in W.A.

News & Events

Fiona Stanley honoured at WA’s most prestigious science awards

Professor Fiona Stanley, Director of the Telethon Institute for Child Health Research, has been inducted into the Science Hall of Fame.

News & Events

Potential new vaccine for WA's meningococcal threat

Perth researchers are trialling a Meningococcal B vaccine that could potentially provide protection

News & Events

Jim McGinty joins child health research Board

Former WA Health Minister, the Hon Jim McGinty, has been appointed to the Board of Perth's The Kids for Child Health Research.

News & Events

Vaccinating society against long-term labour shortages

Community health and education programs may help Australia avert chronic labour and skills shortages in the decades ahead, according to Professor Fiona Stanley.

News & Events

Asthma steroid without side effects

Western Australia has joined a major international study that could significantly change the treatment of asthma in children.

News & Events

Launch of National Autism Guideline

Researchers from The Kids Research Institute Australia, working with the Autism CRC, have led the development of the National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorder in Australia which was launched today.

Research

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses

High-grade gliomas including glioblastoma (GBM) and diffuse midline gliomas (DMG) represent the most lethal and aggressive brain cancers where current treatment modalities offer limited efficacy. Chimeric antigen receptor (CAR) T cell therapies have emerged as a promising strategy, boasting tumor-specific targeting and the unique ability to penetrate the blood-brain barrier.